Overactive Bladder Research This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Ovarian cancer red flags: help prevent delayed diagnosis
This article covers how to spot these red flags, safety netting and what to do if you suspect a woman's symptoms may be ovarian cancer.PMID:38446513 | DOI:10.12968/bjon.2024.33.5.S16 (Source: British Journal of Nursing)
Source: British Journal of Nursing - March 6, 2024 Category: Nursing Authors: Victoria Barber Source Type: research

Nocturia in Menopausal Women: The Link Between Two Common Problems of the Middle Age
AbstractIntroduction and hypothesisThe aim of this review is to discuss the link between menopause and nocturia and to give an overview of the increasing prevalence, risk factors, causative factors, treatment needs and options for nocturia in peri-menopausal women.MethodsThis opinion article is a narrative review based on the expertise and consensus of a variety of key opinion leaders, in combination with an extensive literature review. This literature search included a thorough analysis of potential publications on both the PubMed Database and the Web of Science and was conducted between November 2022 and December 2022....
Source: International Urogynecology Journal and Pelvic Floor Dysfunction - March 4, 2024 Category: OBGYN Source Type: research

Treatment Patterns with Mirabegron and Antimuscarinics for Overactive Bladder: A Prospective, Registry Study in Taiwan and South Korea (FAITH)
ConclusionsMirabegron and solifenacin were commonly prescribed as first-line OAB medications. There was no treatment switch, change, or discontinuation in more than 60% of the mirabegron initiator and antimuscarinics initiator groups. Mean initial treatment duration was 130.8 days and 122.2 days for mirabegron and antimuscarinics, respectively. Graphical Abstract available for this article.Trial RegistrationClinicalTrials.gov NCT03572231.Graphical Abstract (Source: Advances in Therapy)
Source: Advances in Therapy - March 2, 2024 Category: Drugs & Pharmacology Source Type: research

Comparison of mirabegron and vibegron for clinical efficacy and safety in female patients with overactive bladder: a multicenter prospective randomized crossover trial
ConclusionThe efficacies of mirabegron and vibegron in female patients was similar. The patients ’ preference for vibegron could depend on the efficacy of vibegron for urgency incontinence. (Source: World Journal of Urology)
Source: World Journal of Urology - March 2, 2024 Category: Urology & Nephrology Source Type: research

Statin administration ameliorates ischemia-induced overactive bladder with improvement of blood flow and anti-inflammatory effects in rats
CONCLUSIONS: The present results suggest that statins are effective in OAB caused by arteriosclerosis and ischemia. The mechanism of their effects involves improved bladder blood flow and decreased bladder inflammation.PMID:38426742 | DOI:10.1002/nau.25433 (Source: Atherosclerosis)
Source: Atherosclerosis - March 1, 2024 Category: Cardiology Authors: Yuichi Ishizuka Yohei Satake Shingo Kimura Shinichi Yamashita Naoki Kawamorita Akihiro Ito Source Type: research